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ABSTRACT: Fluorescent dye labeling of DNA oligonucleo-
tides and nanostructures is one of the most used techniques to
track their fate and cellular localization inside cells. Here, we
report that intracellular fluorescence, and even FRET signals,
cannot be correlated with the cellular uptake of intact DNA
structures. Live cell imaging revealed high colocalization of
cyanine-labeled DNA oligos and nanostructures with
phosphorylated small-molecule cyanine dyes, one of the
degradation products from these DNA compounds. Nuclease degradation of the strands outside and inside the cell results in a
misleading intracellular fluorescent signal. The signal is saturated by the fluorescence of the degradation product
(phosphorylated dye). To test our hypothesis, we synthesized a range of DNA structures, including Cy3- and Cy5-labeled
DNA cubes and DNA tetrahedra, and oligonucleotides with different stabilities toward nucleases. All give fluorescence signals
within the mitochondria after cellular uptake and strongly colocalize with a free phosphorylated dye control. Kinetics
experiments revealed that uptake of stable DNA structures is delayed. We also studied several parameters influencing fluorescent
data: stability of the DNA strand, fixation methods that can wash away the signal, position of the dye on the DNA strand, and
design of FRET experiments. DNA nanostructures hold tremendous potential for biomedical applications and biotechnology
because of their biocompatibility, programmability, and easy synthesis. However, few examples of successful DNA machines in
vivo have been reported. We believe this contribution can be used as a guide to design better cellular uptake experiments when
using fluorescent dyes, in order to further propel the biological development, and application of DNA nanostructures.
1. INTRODUCTION
DNA- and RNA-based therapeutics, such as antisense
oligonucleotides, aptamers, small interfering RNAs, micro-
RNAs, and the recently developed CRISPR-Cas9 editing tool,
have emerged as highly promising strategies for disease
treatment. Compared to small molecules, oligonucleotides
are highly charged, have a high molecular weight, and are easily
degradable by enzymes. Therefore, one essential element to
their clinical success is their efficient intracellular delivery.1
Poor stability and cellular permeability have hampered the
development of these technologies.2 The fate of these
molecules has been extensively studied, yet they remain
extremely complex to elucidate: many different possible
cellular uptake pathways have been discovered. Differences
observed arise from the sequence, the length of the
oligonucleotide, or the use of chemical modifications, making
almost every molecule unique in its uptake profile.3
More recently, the assembly of DNA and RNA into
nanostructures has been explored as a method to deliver
oligonucleotides and therapeutics.2,4 DNA nanostructures are
easily synthesized and highly programmable, such that arbitrary
shapes and sizes can be efficiently designed.5 Many examples in
the literature have looked at their use in bioimaging,
biosensing, or drug delivery.6 These biocompatible constructs
are more resistant to nuclease degradation than their single-
stranded components and offer complete control over the
position of ligands.7 They can be used to position drug-
encapsulating polymers or protein-binding ligands.8,9 They are
also promising delivery tools for silencing oligonucleotides. For
example, we showed that antisense strands positioned on DNA
cages can induce higher gene silencing than the strands
themselves, when transfected with lipofectamine.10 DNA
nanostructures can also be designed to be dynamic and signal
responsive: they can release a therapeutic upon the recognition
of a mRNA sequence, upon a change of pH, or with light.11−13
All these results have demonstrated the potential to use DNA
nanostructures as drug delivery systems. However, these
structures face challenges similar to those faced by simple
oligonucleotides because they are highly charged and
degradable. One essential element that differs from linear
oligonucleotides is their 3D shape, which has been proposed to
trigger new uptake profiles.6,14 Here again, structures will act
differently according to sequence, length, and presence of
chemical modification, but also its 3D shape and DNA density,
making the analysis of each of these structures unique.
In 2011, Tuberfield et al. reported the cellular uptake of a
double-stranded DNA tetrahedron in mammalian cells.15 The
study showed that cyanine 5 dye (Cy5)-labeled structures were
taken up via endocytosis. By labeling the structure with biotin,
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the authors measured that 2% of the initial tetrahedra was
found inside the cell. Following this important publication,
many groups have explored the uptake of DNA structures in
cells.14,16−18 However, we found that the literature on cellular
uptake of DNA cages was somewhat ambiguous, uptake was
not always quantified, and results greatly vary from one
laboratory to another, due to differences in experimental
design.19 For example, for one structure (tetrahedron), studies
report minimal cell uptake without transfection while other
studies revealed high cell internalization.20,21 In some cases,
uptake was increased by the positioning of aptamers on the
structure.20,21 Other groups described no uptake of cyanine 3
dye (Cy3)-labeled DNA duplex but observed uptake of the
tetrahedron inside cells, which is not consistent with the
above-described first study, where single- and double-stranded
controls were found inside the cell.22 The sequence and length
of the oligonucleotide used as a control is an important
parameter that needs to be carefully studied. The uptake of
larger structures, such as DNA origami, also remains elusive,
and recent studies reported that it depends on both the
nanoparticle shape and the cell line used.23,24 Bastings et al.
used oligolysine-based coating (to prevent degradation) on
DNA structures to study their uptake,24 while other groups
studied the uptake of naked DNA origami.
On the other hand, it is important to highlight some of the
successes made with DNA architectures. In particular, in 2012,
a tetrahedron was decorated with folate to successfully deliver
siRNAs in vivo.25 A DNA icosahedron was used to encapsulate
a fluorescent polymer to track pH changes in Caenorhabditis
elegans.26 DNA origami structures were also used as successful
therapeutic robots by Church et al.27 More recently, a DNA
origami was functionalized with aptamers to target cancerous
endothelial cells, and inhibition of tumor growth was
demonstrated in mice and miniature pigs.28 These examples
demonstrate how careful design of either wireframe DNA
architectures or DNA origami with chosen ligands can lead to a
successful therapeutic device.
Overall, despite the explosion in the number of designs of
DNA nanostructures, and some successes in vivo, the uptake of
naked DNA architectures in cells remains ambiguous.19 We
believe there is a need to understand more precisely what
governs the successful uptake of a 3D DNA structure and its
intracellular fate in cells and in biological fluids. This will give
greater insight into how to design better devices to achieve the
desired therapeutic outcomes. In this paper, we highlight some
important considerations that need to be taken into account
when examining the uptake of DNA structures.
Under non-transfected conditions, uptake of naked DNA
nanostructures is, in general, too low to observe any gene
silencing, similar to oligonucleotides. Therefore, many groups
have looked at uptake pathways by positioning a fluorescent
dye on the structure and tracking the intracellular signal.
Cyanine dyes, and fluorescein to a lesser extent, have been
mostly used since they are available as phosphoramidites and
therefore easy to attach to nucleic acids. However, the
fluorophores themselves can cross the cellular membrane and
accumulate in cell organelles.29−31 We initially questioned
whether the intracellular fluorescent signal corresponds to (i)
dye-guided uptake of the structure (the dye interacts with the
cellular membrane), (ii) degradation of the structure followed
by uptake of the dye, or (iii) unaided cellular uptake of the
intact DNA structure (the small-molecule dye does not play an
important role). Our experiments revealed that the intracellular
fluorescence signal was caused by degradation of the DNA by
extracellular nucleases, leading to release and uptake of the
cyanine dyes. Phosphorylated dyes as models of degradation
products were synthesized, incubated with cells, and
colocalized perfectly with the signal from DNA structures.
We showed that stabilizing the structure toward nuclease
degradation simply delayed the intracellular fluorescent signal.
Serum-free conditions, where extracellular nucleases are
removed, or chemical fixation caused the disappearance of
the signal. Finally, we showed that Förster resonance energy
transfer (FRET), often used to assess integrity of a DNA
structure inside the cells, needs more careful controls when
performed. Notably, we could observe FRET between two
separate, free phosphorylated dyes (Cy3 and Cy5) when they
were co-incubated with cells.
2. DISCUSSION
Assembly of Structure and Design. In this study, we will
focus on wireframe DNA architectures. Our group has
developed DNA minimal nanocages such as cubes, prisms,
and nanotubes. In particular, the DNA nanocube is composed
of four DNA strands (96-mers component strands called
“clips”) that can self-assemble in a one-pot reaction with
quantitative yields.9 The DNA cube displays eight single-
stranded regions (four on the top, and four on the bottom). A
DNA tetrahedron was also prepared, as it is one of the most
used structures in the literature.17 The tetrahedron is also
composed of four DNA strands but is fully double-stranded.
We labeled both structures at the 5′-end with a cyanine dye
using phosphoramidite chemistry: the tetrahedron was labeled
with Cy5, and two clips were prepared for the cube, one with
Cy3 and one with Cy5 (Figure 1). This labeling procedure has
been commonly used in the literature.6 Thermal assemblies
were performed following previous protocols and assessed
using gel electrophoresis (Figure S1).
Cellular Uptake of Cyanine-Labeled Oligonucleotide
and DNA Nanostructures (5′-End). First, we compared the
cellular uptake of the assembled nanostructure with the
corresponding component strand (clip strand, 96-mer for the
cube, 63-mer for the tetrahedron). If DNA nanostructures
were taken up to a higher extent than their single-stranded
components, via new internalization pathways due to their 3D
Figure 1. Cyanine-labeled DNA nanostructures. (A)Two wireframe
DNA-minimal nanostructures were used in the study: the DNA
nanocube, composed of four 96-mers, and the DNA tetrahedron,
composed of four 63-mers. (B) Cyanine dyes (Cy3 on the schema)
were attached at the 5′-end of one of the DNA component clips, using
phosphoramidite chemistry and resulting in a phosphate linkage
between the dye and the base.
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shape, we would observe a difference in their uptake profile.
Structures were added to FBS-containing media and tracked
using confocal live microscopy in HeLa cells at different time
points (1.5, 4, 6, and 24 h). After 1.5 h, we did not detect any
signal for the structures, and the signal for the clips was very
low, suggesting that uptake requires a longer time (Figure S9).
At later time points (4, 6, and 24 h), we observed a similar
uptake profile of the clip strands and the respective DNA
nanostructures, consisting of very bright dots but also long
filaments inside the cytoplasm of the cell (Figure 2 and Figures
S2−S4 and S6−S8). The signals of the clip and the structure
colocalize well (Figure S5).
To ensure that the cellular uptake of the component clip is
not caused by their folding into secondary structures, which
may mimic a 3D scaffold, we looked at the uptake of shorter
5′-end labeled DNA strands (20-mers) and a dinucleotide
(Cy3-TG) (Figures S10 and S11). These short strands
revealed the same fluorescent profile inside cells with dots
and filaments, suggesting that the pattern observed is not
structure-dependent. Cy5-labeled structures and oligonucleo-
tides gave signal distribution similar to that of Cy3-labeled
structures (Figure S4). To gain more insight into the fate of
these structures inside cells, we investigated in which
organelles the structures are accumulating.
Colocalization Analysis Revealed Mitochondrial Ac-
cumulation. Positively charged lipophilic dyes are known to
enter the mitochondria due to electrostatic interactions with
the mitochondrial membrane.32 3,3′-Dihexyloxacarbocyanine
iodide (DiOC6), cyanine dyes, and some Alexa dyes can be
used to stain the mitochondria. Oligonucleotides labeled with
Cy5 or Cy3 have been previously reported as mitochondrial
markers in different cell lines, resulting in long filamentous
fluorescent signal.33,34 Therefore, we tested whether our
structures can accumulate in the mitochondria and used
CellLight Mitochondria-GFP (BacMam 2.0) and CellLight
Lysosomes-GFP (BacMam 2.0) to stain the two organelles
(Figure S12). The BacMam constructs are plasmids encoding
for proteins of the membrane of the organelles fused to Green
Fluorescent Protein. One cube clip, the DNA nanocube, and
the DNA tetrahedron were tested (Figure 3 and Figures S13−
S18). Colocalization analysis, achieved by measuring the
Pearson’s coefficients (PCCs) and Mander’s coefficients
(MCCs), revealed partial colocalization with lysosomes and
the mitochondria.35 For the mitochondria, the structures gave
similar PCCs ranging from 0.4 to 0.5 after 4 h incubation and
0.6−0.8 after 24 h incubation. The increase over time suggests
slow accumulation in this organelle. The partial colocalization
with the lysosome (PCC remains around 0.5−0.6) is
consistent with previous reports in the literature, indicating
uptake of cyanine dyes, oligos, and structures via endosome/
lysosome pathways (Figures S16−S18).16,36,37
While cyanine-labeled oligonucleotides have been reported
to result in mitochondrial fluorescence signals, finding DNA
nanostructures within the mitochondria was surprising and had
never been reported previously in the literature. As pointed out
by Bao et al. when they studied Cy3-labeled short
oligonucleotides, the positive charge of the dye should be
largely compensated by the negative charge of the DNA.33
This makes an entire DNA strand, and to a larger extent a
DNA nanostructure, unlikely to interact with the negatively
charged mitochondrial membranes. However, the results were
the same for the component strands and DNA structures. This
may imply that the overall charge of the molecules does not
impact accumulation to the mitochondria. Another hypothesis
is that the fluorescent signal may simply arise from degradation
of the DNA structure with release of the cyanine dye, which is
known to cross to the mitochondrial membranes. We decided
to investigate whether the fluorescent degradation products,
i.e., the cyanine dye being cleaved from the oligo, can cross the
cellular membrane and stain the mitochondria. Typically,
previous studies have used commercially available versions of
the cyanine dye as controls.34
Phosphorylated Small-Molecule Cyanine Dyes Coloc-
alize with Nanostructures. Upon recognition by exonu-
cleases and subsequent hydrolysis of the phosphate linkage,
two fluorescent degradation products may be produced from
cyanine-labeled oligonucleotides: Cy3-phosphate and Cy3-
hydroxyl (Figure S19). The Cy3-hydroxyl is positively charged,
has almost the same structure than the Cy3 molecule, and is
already known as a mitochondrial marker.33 The Cy3-
phosphate carries at least one negative charge (phosphoester
pKa1 ∼1) that will neutralize the positive charge of the dye. To
our knowledge, its interaction with and within cells remains
unknown. Therefore, we synthesized Cy3-phosphate (Cy3-P)
and Cy5-phosphate (Cy5-P) (Figure 4A and Supporting
Information). Fluorescence spectra reveal emission peaks for
these molecules similar to those for Cy3 and Cy5 dyes, as well
as similar binding to serum proteins in the cellular media
(Figures S22 and S23). The dyes have a lower fluorescence
Figure 2. Uptake of DNA oligonucleotides and DNA nanostructures.
(A) Experimental setup: DNA structures are incubated with
mammalian cells, directly in the cellular media (FBS-supplemented).
Fluorescent signal is detected with confocal microscopy. (Microscope
image credit: Zeiss Microscopy) (B) After 6 h incubation with HeLa
cells, we observed the same fluorescent signal for each DNA
nanostructures and their component clip, using live confocal
microscopy. Representative images are shown in the figure. Scale
bars are 20 μm.
Figure 3. Mitochondrial and lysosomal localization of DNA
structures. Live confocal microscopy in HeLa cells revealed
colocalization of DNA structures. In the image, we represent the
Cy5-labeled DNA nanocube colocalizing with mitochondria and the
Cy3-labeled DNA nanocube with the lysosomes, both after 24 h
incubation. Representative images are shown in the figure.
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intensity compared to the DNA-labeled strands (Figures S82
and S83). Indeed, attaching these fluorophores to DNA likely
increased the local viscosity resulting in higher fluorescence
emission.38
We then incubated the dyes with HeLa cells in FBS-
containing media (1.5 h, 6 h, 24 h). Dyes were taken up
quickly (less than 1.5 h) and gave the exact same filamentous
signal with some bright spots as dye-labeled DNA strands
(Figures S24 and S25). Partial colocalization with mitochon-
dria (Cy5-P) and lysosomes (Cy3-P and Cy5-P) was measured
and showed results similar to those obtained with oligonucleo-
tides and DNA structures (Figures S26−S28). Co-incubating
the two dyes Cy3-P and Cy5-P with cells resulted in complete
colocalization of their respective signals (PCC is ranging from
0.85 to 0.95). (Figure S29). Interestingly, upon co-incubation,
each of our previously tested oligonucleotides and nanostructures
was found to colocalize with the dye (Figure 4B and Figures
S30−S35). Finally, we tested the cellular uptake of the Cy3-
labeled dinucleotide (Cy3-TG), another model for DNA
degradation as it should lead to both potential degradation
products quickly (Cy3-phosphate and Cy3-hydroxyl). Cy3-TG
strongly colocalized with the Cy5-P signal. (Figure S36).
In brief, our degradation model compounds for cyanine-
labeled DNA strands (the phosphorylated dyes) colocalize
with DNA structures. This suggests that the intracellular
fluorescent signal may be caused by the degradation product
entering the cell, i.e., the dye getting cleaved from the DNA,
and not by uptake of the DNA structure. Therefore, it favors
the degradation hypothesis over the hypothesis of the dye
guiding the entire structure to the mitochondria. To confirm
this, we looked at uptake kinetics and synthesized structures
that are more resistant to nuclease degradation. These
structures will lead to a slower release of the cyanine dye
within the cell media, potentially allowing the DNA structure
to enter cells before its degradation by nucleases.
More-Resistant DNA Cubes and Clip Components
Result in Slower Intracellular Fluorescence. When we
examined the kinetics of cellular uptake, we noted that the free
dyes and the free dinucleotide Cy3-TG were taken up in less
than 2 h. Intracellular fluorescence from the 5′-end labeled clip
appears and increases after 2 h, while it takes more than 4 h for
the 3D structures to give a detectable signal (Figure S9). At 24
h, the signal from the clip and the structures are the same.
Similar results were observed by Bao et al. as they studied
different length oligonucleotides.33 We hypothesize that the
delayed signal is caused by a delayed degradation. Indeed,
DNA 3D constructs are more stable than their single-stranded
components.7 Therefore, as it takes more time for nucleases to
digest the strand and for the dye to get cleaved, the
fluorescence signal is delayed. To test this hypothesis, we
synthesized new structures with different serum stabilities,
resulting in different release rates of the cyanine dye.
In serum, 3′-exonucleases are the main cause for DNA
degradation, while inside the cell both 5′- and 3′-exonucleases
will degrade oligonucleotides.39,40 Therefore, labeling the
strand on the 5′-end does not protect it from the main source
Figure 4. Phosphorylated dyes colocalize with DNA structures. (A)
Structures of synthesized phosphorylated cyanine 3 (Cy3-P) and
cyanine 5 (Cy5-P) dyes. (B) Co-incubation of structures and model
for degradation products (free dyes) revealed high colocalization,
using live confocal microscopy in HeLa cells. Representative images
are shown in the figure.
Figure 5. Changing the dye position within the structure. Representative images are shown in the figure. (A) Live confocal microscopy of HeLa
cells (24 h incubation) with the different clips and cubes at fixed laser settings. The experiment revealed that release of the dye at later time points
caused a delay in the appearance of the fluorescent signal. (B) Co-incubation with the phosphorylated dye confirmed colocalization of the more
stable structures with this model for degradation products.
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of nuclease degradation in cell media, leading to a fast release
of the dye. To overcome this stability issue, we synthesized
cube clips with Cy3 and Cy5 positioned at the 3′-end. We also
synthesized two DNA clips with the dye “buried” in the
sequence by changing the position to two different internal
positions: one at the corner of the cube structure (Clip “Cor”),
and one in the single-stranded region (Clip “Mid”) (Figure 5A
and Table S-I). To verify increased nuclease resistance, we
performed serum stability experiments: strands were mixed in
cell media (supplemented with serum, that contains
nucleases), samples were collected at different time points
and analyzed using gel electrophoresis experiments. The half-
life extracted from these experiments reflect the time at which
50% of the full product is still intact, but it does not give us the
exact time of release of the phosphorylated dye degradation
product (Cy3-P or Cy5-P). It is still, however, a good
indication of the relative stabilities of each of the strands.
The half-life of the clip with Cy3 positioned at the 5′-end is
the shortest (52 min), and the 3′-modification dramatically
increased the resistance to extracellular enzymes (236 min).
The two internal positions also increased serum stability but
gave different results (69 min (mid) and 120 min (cor))
(Figures S37 and S38 and Table S-II), most likely due to
sequence dependence of nuclease activity.41 The assembled
DNA cubes have higher stabilities than the clip counterparts
(Table S-III). The different modifications only slightly affected
the overall stability of the cube structure (Figures S41 and
S42). In denaturing conditions of the self-assembled structures,
the 3′-end and the corner modification still have the highest
stabilities, meaning that the dye from these structures should
be released last (Figures S43 and S44).
We incubated the different clips and structures with HeLa
cells and looked at the fluorescent signal using confocal live
microscopy (Figures S53−S64). After 4−5 h incubation, the
uptake of the more stable clips or structures is barely
detectable while the 5′-end clip gives a strong fluorescent
signal. When comparing the intracellular fluorescence, by fixing
the laser settings, the signal of the 5′-end labeled strands and
cubes seems much higher than for the other clips (Figure 5A
and Figure S65). We believe that this difference in intracellular
fluorescence is caused by the slower degradation of the strands,
causing delayed signal. Indeed, at 24 h, our serum stability
experiments revealed that the 5′-end labeled strand is fully
degraded while a smearing on the gel can be observed for the
other strands (3′-, cor, and mid), indicating the presence of a
variety of different length oligonucleotides (Figure S37).
Finally, we co-incubated the phosphorylated dyes with the
different constructs and confirmed the colocalization of the
signal for all the DNA structures at 24 h, by measuring the
PCCs and MCCs (Figure 5B and Figures S53−S64).
In short, as we slow down degradation and dye release, the
signal appears slower for cube clips and cubes, strengthening
the hypothesis of degradation of the structure followed by
cellular uptake of the dye (or short dye-labeled oligonucleo-
tides). Results were confirmed in another cancer cell line,
HepG2 cells (liver hepatocellular cells). We observed cellular
uptake of the dyes and delayed uptake of the 3′-end labeled
structure. (Figures S94−S98). To confirm further that stable
structures are taken up later, we looked at the DNA
tetrahedron, which is fully double-stranded and more resistant
to nucleases.
Hexaethylene Glycol To Prevent DNA Tetrahedron
Degradation. The tetrahedron structure has been extensively
investigated in biological studies.17 However, in our hands, the
assembly of the tetrahedron led to multiple higher mobility
products in the gel, indicating the formation of higher-order
assemblies (Figure S1).42,43 We used this mix of products for
our studies, as the protocol has been widely used by the
community (Supporting Information).17,44 We also purified
the tetrahedron structure using electrophoretic methods, to
further confirm our results with the monodisperse structure
(Figure S1).
To prevent the release of the dye, we synthesized a
fluorescently labeled clip protected by hexaethylene glycol
units (HEG) at both the 3′- and 5′-ends. The HEG
modification increased resistance to nuclease degradation
(Figures S39 and S40, and Tables S2 and S3). The
modification did not affect the overall stability of the
Figure 6. HEG-protection of the DNA tetrahedron. (A) Chemical structure of HEG modification. (B) Gel electrophoresis from serum stability
experiments. The component clip of the tetrahedron revealed higher stability of the clip component upon HEG-labeling at 5′- and 3′-ends. Cy5
channel is displayed. (C) Live confocal microscopy (HeLa cells, fixed laser settings) revealed that the more stable structures caused a delayed
cellular uptake. Scale bars at 20 μm. Representative images are shown in the figure.
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tetrahedron, but the clip from the structure is more stable
(Figures S45, S46, S48, and S49). Incubation with cells led to
similar conclusions: the HEG protection, as it increased the
nuclease resistance, significantly delayed the cellular uptake
(Figure 6 and Figures S67 and S68). Co-incubation of Cy3-P
with tetrahedron, purified tetrahedron, and HEG-protected
tetrahedron confirmed colocalization with the degradation
product (Figures S66−S72). Results were confirmed in HepG2
cell line as well (Figures S99−S102).
At early time points (4 h), we observed very faint dots (laser
power and gain were increased) from the DNA structure that
do not colocalize with the dye (Figures S67 and S68), possibly
due to very low uptake of intact structures or oligos, consistent
with the 1−2% uptake observed by Turberfield et al.15 These
strands eventually degrade after cellular uptake (endosomal pH
and cytoplasmic nucleases), releasing the dye as well. All these
experiments indicate that as we stabilize the dye-labeled DNA
strand, the fluorescent signal is simply delayed. We then
investigated other methods to prevent DNA degradation and
dye uptake, such as changing serum conditions or using
negatively charged fluorescent dyes, to further assess the serum
degradation hypothesis.
Changing Serum Conditions To Prevent DNA
Degradation. To prevent extracellular nuclease degradation,
we tested uptake in low-serum conditions (0.1% FBS instead of
10%). At 0.1% FBS concentration, nuclease degradation should
be dramatically reduced. We did observe uptake of the free
dyes; however, uptake of 5′-end-labeled clip and cube, as well
as of the 3′-end-labeled clips, was considerably reduced
(Figure 7A and Figures S73−S75). This seems to indicate
that our DNA constructs need to be degraded to produce a
detectable signal. We also performed “pulse-chase” experi-
ments where structures are incubated in serum-free conditions
(0% FBS) for 15−20 min, cells are washed, and new cell
culture media (10% FBS) is then added.45 Much lower signal
could be detected, and after 1 day incubation, we did observe
the same pattern than for degraded products (filament and
dots) (Figure S76). More stable structures gave a delayed
signal compared to less stable ones (3′- vs 5′-Cy3 cubes),
suggesting uptake of the degraded product (Figure S77).
Curiously, this result suggests binding or low uptake of some
structures into the cell, which are not washed away by the
washing steps and are eventually getting degraded.
Sulfonated Cyanine Dyes Do Not Accumulate in the
Mitochondria. Negatively charged sulfonate groups are
typically placed on cyanine dyes to increase their solubility
in water, avoid dye aggregation, and prevent their cellular
uptake.46 We used click chemistry and one of our previously
developed phosphoramidites to label the cube clip with a
sulfonated Cy5 at its 5′-end or in an internal position (Figure
7B and Figures S91 and S92).47 The sulfonated clip and cube
gave little fluorescent signal inside cells compared to the non-
sulfonated Cy5 (Figure 7C and Figure S93). This means that
the intracellular fluorescence is dye-dependent and that low
fluorescent signal, sometimes observed from other dyes can
not be correlated with uptake of the structure. We believe that
the observation of a fluorescent signal should always be
followed by a quantification of the uptake. For example,
quantification methods such as streptavidin−biotin labeling or
qPCR methods revealed low uptake of nanostructures inside
cells.16,48
In conclusion, all our experiments are consistent with prior
degradation of the cyanine-labeled dye, followed by uptake of
the fluorescent dye inside the cell, leading to most of the
observed fluorescent signal. Previous research from various
laboratories has indicated uptake of DNA nanostructures
through endosomal pathways and used FRET experiments to
prove their integrity inside cells. These results are in apparent
contradiction with our observations, and we therefore
examined FRET experimental design in more details.
Free Dyes Cy3-P and Cy5-P Can Give an Intracellular
FRET Signal. DNA structures can easily be labeled with a
FRET pair, for example Cy3/Cy5.15,49 Precisely two
components strands are labeled: one with Cy3 (donor), one
with Cy5 (acceptor), such that the two dyes are close enough
(1−10 nm) to allow energy transfer upon excitation of Cy3. If
the structure is disassembled, no energy transfer will happen.
Therefore, the observation of FRET signal intracellularly is in
general explained by invoking the uptake of an intact structure.
As shown above, we observed that the two free dyes highly
colocalize in cells (Figure S29). We believe this is due to their
high local concentration in the lysosome and their accumu-
lation in the mitochondria. We decided to test whether these
two separate dye molecules can give a FRET signal inside live
cells, giving rise to an “incorrect FRET signal” (sometimes
called random FRET).50 We synthesized a positive control for
FRET: a DNA strand labeled with Cy3 and Cy5 directly
attached to one another via a phosphodiester bond at the 5′-
end called strand Cy3-Cy5 (Table S-I). Emission spectra
confirmed that the strand Cy3-Cy5 causes FRET emission in
DMEM (cell media) and FBS-supplemented DMEM, while no
signal was observed for the free dyes or for mixture of dyes
with labeled DNA strands (Figures S82−S84). The Cy3-Cy5
Figure 7. Lowering serum conditions and changing the dye to its
sulfonated version. Representative images are shown in the figure. (A)
Live confocal microscopy in HeLa cells in low-serum conditions
(0.1% FBS) revealed that with reduced degradation, no fluorescent
signal is observed. (B) Chemical structure of sulfonated Cy5 dye,
negatively charged. (C) Structures labeled with sulfonated dye did not
produce any intracellular fluorescent signal compared to non-
sulfonated labeled structures.
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phosphate bond in the strand Cy3-Cy5 remains stable upon
addition of serum (Figure S85), confirming it can be used as a
positive control.
We then examined FRET signals in live cells at 6 and 24 h,
using confocal microscopy. Structures and dyes were incubated
at 150 nM final concentration. After background and cross-talk
corrections, we calculated the FRET/Cy3 ratio to quantify
energy transfer.51 Surprisingly, we observed high FRET signal
when the two free phosphorylated dyes Cy3-P and Cy5-P were co-
incubated, while the FRET-positive strand gave a smaller signal
(Figure 8 and Figures S88−S90). At 6 h, the ratio is high for
the two co-incubated dyes and for the 5′-end-labeled clip co-
incubated with free dye. The positive control, the strand Cy3-
Cy5, gives almost no signal. We believe full DNA degradation
was not reached at this time point and that the linked dyes
from the degraded DNA strand had not yet entered the cell to
a high extent (Figure S85). At 24 h, the strand Cy3-Cy5 gives a
small signal, less than that of the two free dyes. Interestingly, co-
incubating a Cy3-labeled DNA strand (5′-end, less stable) with a
separate Cy5-labeled DNA strand (3′-end, more stable) resulted in
a measurable FRET/Cy3 ratio, albeit lower than the two free dyes,
consistent with the degradation hypothesis. Overall, the fact that
we can observe random FRET signal with two separate small-
molecule dyes supports the need of carefully designed controls
for FRET experiments with DNA strands and structures. The
signals from the free dyes should be studied, or two chemically
different dyes should be used.
Fluorescent Signal Is Washed Away by Chemical
Fixation. Another important parameter to compare our work
to other studies in the literature is the use of live confocal
microscopy to prevent effects from the fixative agents on the
fluorescent signal. Cyanine dye accumulation inside the
mitochondria does not resist chemical fixative agents like
formaldehyde.32 We tested whether the signal is disrupted by
chemical fixation. When we fixed cells with formaldehyde, the
filamentous signal of the phosphorylated dyes disappeared, and
we saw only bright dots (endosome/lysosomes) and diffuse
cytoplasmic signal (Figure S78). The result was similar for
oligonucleotides (Figure S79), but Cy3-P and Cy5-P still
colocalized (Figure S80). Methanol fixation removed all the
fluorescent signal or caused DNA precipitation (Figure S81).
This emphasizes that the effect of chemical fixation needs to be
carefully studied since it can cause misleading information.
Safety Statement. No unexpected or unusually high safety
hazards were encountered in the course of this work.
3. CONCLUSION
The observation of colocalized signals when DNA structures
and their degradation products are administered to cells
indicates that intracellular fluorescence does not necessarily
correlate with cellular uptake. Instead, experiments revealed
that most of the signal arises from degradation of DNA
structures by nucleases, releasing the fluorescent dye that is
then taken up inside cells. In particular, we observed that, as we
stabilized the dye within the structure, uptake was delayed.
Changing the dye to its cell-impermeable version (sulfonated)
or preventing serum degradation considerably reduced the
intracellular fluorescence. Interestingly, FRET signals were
observed between the separate free cyanine dyes inside cells,
revealing the need for more carefully designed controls when
using FRET experiments to assess uptake of intact DNA
structures. Protocol design, such as the use of chemical fixation
instead of live conditions, can also dramatically change the
pattern of the fluorescence signal.
In this study, we focused on wireframe DNA-minimal
architectures. However, we believe that the findings can be
extended to any nucleic acid-based material, such as DNA
origami or RNA therapeutics, as nucleases can still access and
degrade the labeled strands. DNA-dense structures such as
DNA origami may have different degradation profiles than
wireframe structures, but they are still prone to nuclease
degradation within a few hours and disassembly as the dication
concentration is lower in biological media.52 The fluorescent
dye to track DNA origami cellular uptake is often placed at the
5′- or 3′-end of the short staple strands and can protrude from
the surface of the origami.53 Embedding the dye within the
structure was shown to result in a longer stability of the FRET
signal, coherent with longer structural integrity.54
Beside the signal from the degradation product, the
fluorescence signal and intensity will depend on many
Figure 8. Förster resonance energy transfer (FRET) experiments. (A) Live confocal microscopy after 24 h incubation in HeLa cells. Representative
images are shown in the figure. (B) Quantification of the gray level intensity from the microscopy experiments (detailed protocols in the
Supporting Information). These two experiments revealed that the two free separate small molecules can give a FRET signal, even though they are
not in close proximity before incubation.
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parameters linked to the nature of the dye: binding to serum
proteins can increase fluorescence, as can sequence-specific
attachment to a DNA strand.46,55 Cellular localization is
known to influence the brightness of the dye, for example
because of changes of pH in the different organelles.56
Therefore, altered fluorescence intensity could simply arise
from longer retention in the endosomal compartment, where
the dye may be brighter or dimmer (lowed pH). We believe
that measuring the total fluorescence intensity in a cell, for
example by using flow cytometry, cannot be simply correlated
with higher uptake of a structure. Precise colocalization and
fluorescence analysis need to be performed.
Furthermore, our results may indicate that cyanine dyes may
not be an ideal choice for the investigation of cellular uptake of
DNA structures. Cyanine dyes fluorescence is strongly
dependent on its local environment.38 On the other hand,
the cell permeability of the cyanine dyes allowed us to detect
the uptake of the degradation products inside the cell. It is
important to note, however, that using other types of dyes
would not prevent the fluorescent molecule from getting
cleaved off the DNA strand; they would simply change the
intensity or location of the intracellular fluorescent signal
arising from degradation. The absence of a signal can be
difficult to study, as it could just indicate issues with the
experimental setup. Overall, we believe that, in addition to
choosing the dye carefully, control experiments involving a
phosphorylated f ree dye as a model of degradation, rather than
only unsubstituted dye, should be systematically performed
when using fluorescence methods such as microscopy, flow
cytometry, or FRET. Two chemically different dyes can be
used to confirm that the results observed are not dye-
dependent.
Thorough quantification of the uptake of the DNA structure
is also needed if the structure is thought to enter the cell. Non-
fluorescent methods such as gene silencing experiments,
qPCR, or biotin-labeling can be used for quantification.
Overall, our results can be used as a cautionary tale on how
to design and analyze fluorescence experiments when
examining the uptake profile of DNA-based materials. For
fluorescence-based assays, we recommend (a) comparison of
uptake with model of degradation products (such as the
phosphorylated dye, even for FRET experiments), (b)
correlation of degradation kinetics with cellular uptake kinetics,
(c) thorough controls and optimization of the cellular work
conditions (serum, fixation, temperature), and (d) changing
the nature and position of the dye to track whether the signal is
dye-dependent or not (and trying to place the dye in less
accessible positions on the labeled oligonucleotide).
Finally, our findings bring new important considerations for
the use of DNA nanostructures in biological systems. First, we
believe that our results may not be contradictory with
previously reported successful examples of DNA nanostruc-
tures inside cells, but instead they provide clues on the design
of more reliable fluorescence-based assays. We hope they will
help the community deciphering the rules that govern the
successful uptake of certain DNA structures compared to
others.
We also believe that revealing that wireframe DNA
nanostructures do not enter cells to a high extent can be
turned into a real advantage in using them as drug delivery
devices. Nonspecific cellular uptake of DNA cages is not
desirable, as it would mean that cages can penetrate different
cells in vivo. Instead, it gives us the opportunity to attach
targeting ligands on these cages to promote their entry into
specific cellsfor example, folate decoration can lead to
internalization into cancer cells.25 To increase cellular uptake,
inspiration can also be taken from the extensive work done by
the oligonucleotide therapeutics field. Specifically, we believe
that inserting chemical modifications in DNA (nucleobase,
backbone, 3′- and 5′-end modifications) could reduce nuclease
degradation while substantially increasing uptake of DNA
cages.57 On the other hand, because of their poor uptake, DNA
nanostructures could be used as biosensors or bioimaging
systems outside of the cell.27,28 Their programmability and
higher nuclease resistance compared to single-stranded DNA
make them excellent biodegradable materials to sense the cell
surface or extracellular proteins. They could also be used to
promote cell−cell interaction, by targeting membrane
receptors.58 Finally, as drug delivery systems, they could also
be designed to carry small-molecule drugs. The DNA cage
degradation could lead to a slow release of the drug that can
then be internalized by the targeted cells. Stabilizing the
structure, to control the rate of drug release, can be achieved
by the introduction of chemical modifications in the bases or
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